Nanoly Bioscience Inc

Keeping therapeutics thermally stable results in high delivery costs. We aim to enable vaccines to survive without refrigeration and decrease these costs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boulder, CO, US
  • Currency USD
  • Founded 2012
  • Employees 0
  • Website nanoly.info

Company Summary

We are developing a thermal stabilization platform technology for temperature- sensitive vaccines and medicines, using a safe, low cost, and scalable polymer that is well understood. Nanoly's encapsulation and photo-release approach introduces minimal changes to administrative protocol for the vaccine or medicine. Our goal is to enable immunization access anywhere while simultaneously eliminating the refrigeration cost for lifesaving medicine.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free